The study

What is public, and nothing more.

Acuence reads how the skin appears in a photo taken on iPhone. This page states what the app observes, what it refuses to display, and where its evaluation stands, with a date.

No results published · status as of October 29, 2026

0scientific results published to date

Scope

Observing appearance. Nothing beyond.

Acuence returns cosmetic observations. It names no condition and evaluates no treatment.

Out of scope

  • Diagnosis
  • Medical condition
  • Treatment assessment

What the app observes

How the skin appears, in a photo of the face.

  • Redness
  • Texture
  • Dark circles
  • Shine

Measurements are computed on the iPhone, from the photo.

A reading

A photo, a reading, or nothing.

The path has four steps. The third may stop right there: that is by design.

  1. Taking the photo

    A photo of the face, taken on your iPhone.

  2. Does the photo allow it?

    A reading is only made when the image allows a reliable one.

  3. Reading

    A cosmetic observation of how the skin appears.

    or “Not readable”

    Nothing is shown. A result only counts if it can be defended.

  4. On your iPhone

    The face photo stays on the device; the reading joins your history.

Status of the work

Stating exactly what is public today.

No scientific result is published on acuence.app as of this date. No conclusion is therefore presented as established.

Public results
None to date
Status checked on
Next publication
No date announced

Public milestones

  1. Done

    Trademark filed

    INPI no. 5271632, on June 24, 2026.

  2. Done

    Patent applications filed

    FR2608416 and FR2610880, with the INPI.

  3. Upcoming

    Availability on the App Store

    Announced by a single email to those who signed up.

  4. Upcoming

    First published synthesis

    Dated, versioned, with its limits. No date announced.

Publication commitment

Making conclusions as readable as their limits.

  • Scope

    Each conclusion will be tied to what it documents, with no extension to medical use.

  • Limits

    Identified limits will be published with the same visibility as the results.

  • Traceability

    Each synthesis will carry a date, a version number and the identity of its contributors.

Until a synthesis can be published, Acuence sticks to describing its cosmetic use.

Soon on the App Store

Acuence is coming to iPhone.

Enter your email address. We will write to you once, when Acuence is available on the App Store.

Your email address is processed on the basis of your consent, only to notify you at launch. It is received by the publisher, Guillaume Velé; the server is hosted by OVH SAS. It is kept until the launch message is sent or until you ask for its deletion, whichever comes first. To exercise your rights or withdraw your consent, write to contact@acuence.app. You may also lodge a complaint with the French data protection authority, the CNIL (cnil.fr). Details in the privacy policy.